Encompass Health 3Q 2026: Revenue $1.61B, EPS $1.5— 10-Q Summary
Encompass Health reported Q3 2026 revenue of $1.61B, up 8.9% YoY, and net income of $203.6M, up 16.6%. Diluted EPS rose 21% to $1.5. Growth was driven by higher patient volumes and pricing. The company expanded with four new hospitals and 85 additional beds.
How this was made
The 30-second read
Why it matters
Investors can update near-term estimates based on reported revenue, net income, and EPS, and reassess reimbursement mix given Medicare Advantage declined while overall Medicare share increased.
Market read
A company-specific earnings print with operating drivers (discharges, Medicare mix) that can move expectations for rehab demand and reimbursement mix.
What to watch
The summary does not quantify margins, bad debt, staffing costs, or guidance for 2027, which are key for translating volume growth into earnings durability.
Background
The piece is a brief 10-Q summary for Encompass Health’s third quarter of 2026, highlighting financial results and operating metrics.
Ticker impact
Encompass Health reported 3Q 2026 revenue of $1.61B and diluted EPS of $1.50, with growth tied to higher patient volumes and pricing.
Likely modest upward bias as investors focus on volume and EPS growth, partially offset by the Medicare Advantage mix decline.
The article provides a full quarterly snapshot (revenue, net income, EPS) plus operating drivers (discharges, Medicare mix) that can influence near-term earnings expectations and margin/mix perceptions.
Market effects
Rehab/behavioral healthcare operators may see read-across interest from discharge growth and Medicare mix trends.
No specific regional demand signal beyond aging-demographics commentary.
Primarily US Medicare-driven healthcare demand, limited global spillover.
Counterpoint
Medicare Advantage share declined, which could pressure reimbursement economics even if total Medicare revenue rose.
Key entities
- companyEncompass Health
US inpatient rehabilitation provider reporting 3Q 2026 results and operating metrics in a 10-Q summary.
